Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 890(2): 347-50, 2001 Feb 02.
Article in English | MEDLINE | ID: mdl-11164803

ABSTRACT

In order to analyze the putative neuroprotective role of nicotine and cotinine in parkinsonian syndromes, these two compounds were administered in male C57Bl6 mice for 4 weeks. On day 8, four injections of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (MPTP) were administered. MPTP intoxication induced a 50% loss of dopaminergic neurons in the substantia nigra and a 45% reduction in dopaminergic fibers in the striatum. Administration of cotinine did not affect MPTP toxicity in the nigrostriatal system but chronic nicotine treatment showed a slight protection (15%) of nigrostriatal dopaminergic neurons against MPTP.


Subject(s)
Axons/drug effects , Cotinine/pharmacology , Dopamine/metabolism , Neuroprotective Agents/pharmacology , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Parkinsonian Disorders/prevention & control , Animals , Axons/metabolism , Axons/pathology , Male , Mice , Mice, Inbred C57BL , Neostriatum/drug effects , Neostriatum/pathology , Neostriatum/physiopathology , Nerve Degeneration/drug therapy , Nerve Degeneration/physiopathology , Nerve Degeneration/prevention & control , Parkinsonian Disorders/drug therapy , Parkinsonian Disorders/physiopathology , Substantia Nigra/drug effects , Substantia Nigra/pathology , Substantia Nigra/physiopathology , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...